MFIC

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Apollo Investment Corporation (Note: The input metadata listed "Midcap Financial Investment Corp," but the filing text identifies the registrant as Apollo Investment Corporation) for the quarterly period ended September 30, 2016. Apollo Investment Corporation is a closed-end, externally managed, non-diversified business development company (BDC) and a regulated investment company (RIC). The company invests primarily in debt and equity of private middle-market companies.

Key Financial Metrics

Material Changes vs. Prior Period

• Investment Income Decline: Total investment income decreased by approximately $54.6 million (27%) compared to the prior year period. This was driven by a $39.4 million decrease in interest income and a $10.9 million decrease in dividend income, attributed to a lower income-bearing portfolio and an increase in non-accrual status investments.
• Expense Reduction: Net expenses decreased by $29.7 million. This was primarily due to a $20.4 million reduction in management and incentive fees (net of waivers) and a $13.0 million decrease in interest and debt expenses following the repayment of Senior Secured Notes and Convertible Notes.
• Realized Gains vs. Losses: The company reported net realized gains of $5.5 million for the six months ended September 30, 2016, a significant improvement from net realized losses of $111.1 million in the prior year period. Significant gains included $46.1 million from Generation Brands Holdings, Inc., while significant losses included $19.5 million from Osage Exploration & Development, Inc.
• Unrealized Losses: Net change in unrealized losses was $82.1 million, compared to a net change in unrealized gains of $15.2 million in the prior year. Significant unrealized losses were recorded for Generation Brands Holdings, Inc. ($43.8 million) and Garden Fresh Restaurant Corp. ($33.9 million).
• Debt Reduction: Total debt outstanding decreased by approximately $298 million, reducing the average debt outstanding from $1.47 billion to $1.13 billion.

Guidance, Outlook, Risks, and Unusual Items

• Fee Waivers: The Investment Adviser waived 25% of the base management fee (reducing it to 1.50%) and up to 25% of the performance-based incentive fee for the period April 1, 2016, through March 31, 2017, contingent on cumulative net losses.
• Share Repurchases: The company repurchased 4.16 million shares during the six-month period at a weighted average price of $5.85, representing a discount of approximately 16.95% to the average NAV. As of September 30, 2016, $63.2 million remained available under repurchase plans.
• Non-Accrual Status: As of September 30, 2016, 3.9% of total investments at fair value were on non-accrual status, up from 4.2% at March 31, 2016 (though the percentage of amortized cost increased from 8.4% to 11.1%).
• Legal Proceedings: The company is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings alleging fraudulent conveyance, seeking approximately $41 million in damages. The company intends to vigorously defend itself. Additionally, affiliates of the Investment Adviser settled an SEC matter regarding fee disclosures, agreeing to pay $37.5 million in disgorgement and a $12.5 million penalty.
• Accounting Change: The company adopted ASU 2015-03 and ASU 2015-15, changing the presentation of debt issuance costs from an asset to a direct deduction from the carrying amount of debt.

Investor Verification Checklist

• Non-Accrual Exposure: Verify the specific portfolio companies on non-accrual status and the likelihood of recovery, given the increase in non-accrual assets at amortized cost.
• Fee Waiver Sustainability: Confirm the duration and conditions of the management and incentive fee waivers, as they significantly impact current expense ratios.
• Debt Covenants: Review compliance with the Senior Secured Facility covenants, particularly the asset coverage ratio and borrowing base limitations, given the high leverage.
• Legal Liability: Assess the potential financial impact of the DSI Renal Holdings litigation and the SEC settlement involving affiliates.
• PIK Income: Evaluate the reliance on Payment-in-Kind (PIK) income, which totaled $12.5 million for the period, and its impact on cash flow versus reported income.